Head to head
GoodRx vs Veeva Systems
Side-by-side on the measures that matter, with a plain-English read. Full detail: GDRX · VEEV
GDRX
GoodRx
3.25-0.61%
1-year price shape — -26% over the period
Quant Rating C · 59/100
vs
VEEV
Veeva Systems
282.50-0.35%
1-year price shape — -8% over the period
Quant Rating D · 32/100
1-year performance, rebased to 100
Veeva Systems edges it on the scoreable measures. Veeva Systems has done best over the past year (-8%); Veeva Systems trades cheapest on trailing earnings; Veeva Systems earns the most per share.
| GDRX | VEEV | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Health Information Services |
| Last price | 3.25 | 282.50 |
| Change today | -0.61% | -0.35% |
| 1-year return | -26.0% | -7.7% |
| Market cap | $1.11B | $45.74B |
| 52-week range | 1.77 – 4.33 | 148.05 – 302.17 |
| Valuation | ||
| P/E (TTM) | 54.17 | 46.31 |
| P/E percentile, own 5-yr range | 77th | 16th |
| P/B | 1.71 | 6.15 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 0.09 | 5.44 |
| Net profit (TTM) | $30.70M | $880.78M |
| Revenue (TTM) | $785.23M | $3.46B |
| Revenue growth (YoY) | -1.3% | +17.6% |
| Gross margin | 90.8% | 75.0% |
| Operating margin | 9.5% | 29.9% |
| Net margin | 2.1% | 29.3% |
| Free cash flow (TTM) | $131.70M | $1.67B |
| Ownership & sentiment | ||
| Institutional ownership | 45.5% | 91.0% |
| Insider activity (12mo) | 28 buy / 16 sell | 29 buy / 18 sell |
| Short interest (% of float) | 1.4% | 3.1% |
| Analyst consensus | 44% buy / 44% hold / 11% sell (9) | 73% buy / 23% hold / 5% sell (22) |
| Analyst price target | $4 (+30%) | $295 (+4%) |
| StockVane view | ||
| StockVane Quant Rating | C (59) | D (32) |
| Company | ||
| Employees | 697 | 7,928 |
| Founded | 2011 | 2007 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.